Feasibility Study: Continuous Fetal Monitoring During Maternal Exercise
NIEM-S
Continuous Non-invasive Electrophysiological Monitoring During Maternal Exercise: a Feasibility Study
1 other identifier
interventional
15
0 countries
N/A
Brief Summary
This feasibility study will be the first study to assess the feasibility of continuous electrophysiological monitoring during maternal exercise in women with an uncomplicated pregnancy. This may help to better understand fetal condition during exercise and offer personalised exercise recommendations in the future. In future, validating the feasibility and safety of exercise could promote greater exercise engagement among pregnant women and increase fetal wellbeiing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable pregnancy
Started Oct 2025
Shorter than P25 for not_applicable pregnancy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
July 22, 2025
CompletedStudy Start
First participant enrolled
October 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2026
CompletedJuly 28, 2025
July 1, 2025
3 months
April 22, 2025
July 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success rate of continuous electrophysiolgoical monitoring during maternal exercise
Defined as the percentage of time during continuous maternal exercise with concurrent signal output of the fetal heart rate. Continous electrophysiological monitoring is feasible by a successrate of =\>80%
15 minutes (min) before, 30 min during and 15 min after maternal exercise
Secondary Outcomes (12)
Maternal heartrate
15 min before, 30 min during and 15 min after maternal exercise
Mean maternal heartrate
15 min before, 30 min during and 15 min after maternal exercise
Fetal heart rate variability
15 min before, 30 min during, 15 min after exercise
Fetal heart rate
15 min before, 30 min during and 15 min after maternal exercise
Contraction frequency
15 min before, 30 min during and 15 min after maternal exercise
- +7 more secondary outcomes
Study Arms (1)
Electrophysiological monitoring
EXPERIMENTALSee intervention
Interventions
electrofysiological CTG monitoring with the Nemo Fetal Monitoring System (Nemo Healthcare B.V., Veldhoven, the Netherlands). The NFMS consists of a wireless and beltless electrode patch on the maternal abdomen. It monitors fetal heart rate by fetal electrocardiography, maternal heart rate by maternal electrocardiography and the electrical activity of the uterine muscle by electrohysterography.
Eligibility Criteria
You may qualify if:
- Minimal age of 18 years old
- Pregnant women with an uncomplicated singleton pregnancy and a gestational age between 30+0 and 40+0 weeks and days
- Oral and written informed consent is obtained
- Engage in aerobic exercise during pregnancy
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Insufficient knowledge of Dutch or English language
- Women with a multiple pregnancy
- Contra-indications for the Nemo Fetal Monitoring System (NFMS):
- Fetal and/or maternal cardiac arrhythmias
- Contraindications to abdominal placement (dermatologic diseases of the abdomen precluding preparation of the abdomen with abrasive paper)
- Women connected to an external or implanted electrical stimulator, such as a pacemaker (because of disturbance of the electrophysiological signal)
- Fetus with known congenital or chromosomal abnormalities
- Mild or severe respiratory diseases (e.g. chronic obstructive pulmonary disease, restrictive lung disease and cystic fibrosis)
- Mild or severe acquired or congenital heart disease with exercise intolerance
- Uncontrolled or severe arrhythmia
- +16 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Simone Goossens, PhD
Principal Investigator
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor, PhD Candidate, Coordinating Investigator NIEM-S study
Study Record Dates
First Submitted
April 22, 2025
First Posted
July 22, 2025
Study Start
October 15, 2025
Primary Completion
December 31, 2025
Study Completion
March 13, 2026
Last Updated
July 28, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
All IPD that underlie results in a publication